June 22, 2023
Howard Leads First Successful Clinical Trial of RNA Cell Therapy in Autoimmune Disease
Published in The Lancet Neurology, a study led by James Howard, MD, professor of neurology at the UNC School of Medicine, showed how an RNA CAR-T therapy developed by Cartesian Therapeutics can dramatically improve symptoms in patients with myasthenia gravis, an autoimmune disorder.